Routine buyback update with no deviation from announced pace. Monitor for any acceleration or suspension of the program, which would signal a change in capital allocation priorities.
Price Chart
Executive Summary
Novo Nordisk filed a 6-K disclosing weekly B-share repurchase transactions under its ongoing DKK 15 billion buyback program. From October 12-16, 2026, the company repurchased 1,225,000 B shares for approximately DKK 316 million, bringing the total under the current tranche to 24,315,000 shares for DKK 7.075 billion. The filing is a routine periodic update with no material new information.
Key Facts
- Weekly repurchase of 1,225,000 B shares from Oct 12-16, 2026 for ~DKK 316 million
- Total accumulated under the current program: 24,315,000 B shares for DKK 7,075,024,314
- Overall program: up to DKK 15 billion from Feb 4, 2026 to Feb 1, 2027
- As of Oct 16, 2026, total repurchased since Feb 4: 39,074,179 B shares at avg DKK 278.32 for DKK 10,875,024,304
- Treasury shares now total 53,114,876 B shares, or 1.2% of total share capital of 4,465,000,000 A+B shares
Financial Impact
DKK 316 million in weekly buyback execution; cumulative DKK 10.875 billion deployed toward a DKK 15 billion program
Risk Factors
- No material risks disclosed in this routine filing
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-006685 |
| Document: 0001171843-26-006685-index-headers.html | 0001171843-26-006685 |
| Document: 0001171843-26-006685-index.html | 0001171843-26-006685 |
| Document: 0001171843-26-006685.txt | 0001171843-26-006685 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 2d ago | 6-K | $39.13 | awaiting T+20 | awaiting T+20 | $38.29 (−2.15%) |
Oct 26, 2026 3d ago | Court Ruling | $38.67 | awaiting T+20 | awaiting T+20 | $38.29 (−0.98%) |
Oct 19, 2026 9d ago | 6-K | $38.42 | awaiting T+20 | awaiting T+20 | $38.29 (−0.34%) |
Oct 13, 2026 15d ago | 6-K | $38.06 | awaiting T+20 | awaiting T+20 | $38.29 (+0.60%) |
Oct 6, 2026 22d ago | 6-K | $37.53 | awaiting T+20 | awaiting T+20 | $38.29 (+2.03%) |
Sep 28, 2026 4w ago | 6-K | $38.71 $38.95 | ▲ +0.61% | ▲ +0.64% | $38.29 (−1.08%) |
Sep 23, 2026 5w ago | Court Ruling | $38.62 $39.43 | ▲ +2.10% | ▲ +2.52% | $38.29 (−0.85%) |
Sep 21, 2026 5w ago | 6-K | $39.80 $38.42 | ▼ −3.47% | ▼ −2.56% | $38.29 (−3.79%) |
Sep 17, 2026 5w ago | 6-K | $43.19 $39.22 | ▼ −9.19% | ▼ −10.40% | $38.29 (−11.35%) |
Sep 15, 2026 6w ago | 6-K | $42.53 $38.06 | ▼ −10.51% | ▼ −13.23% | $38.29 (−9.97%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers